Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Intestinal perforation? 240 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 240 reports of Intestinal perforation have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.3% of all adverse event reports for DOXORUBICIN.

240
Reports of Intestinal perforation with DOXORUBICIN
0.3%
of all DOXORUBICIN reports
86
Deaths
112
Hospitalizations

How Dangerous Is Intestinal perforation From DOXORUBICIN?

Of the 240 reports, 86 (35.8%) resulted in death, 112 (46.7%) required hospitalization, and 32 (13.3%) were considered life-threatening.

Is Intestinal perforation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 240 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Intestinal perforation?

ADALIMUMAB (1,010) BEVACIZUMAB (600) RITUXIMAB (321) TOCILIZUMAB (276) PREDNISONE (266) CYCLOPHOSPHAMIDE (262) LENVATINIB (228) INFLIXIMAB (226) PEMBROLIZUMAB (220) METHOTREXATE (202)

Which DOXORUBICIN Alternatives Have Lower Intestinal perforation Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Intestinal perforation Reports All Drugs Causing Intestinal perforation DOXORUBICIN Demographics